These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 21337139)

  • 1. Antibiotic susceptibility testing.
    Block C
    Methods Mol Med; 2001; 67():89-106. PubMed ID: 21337139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Standardization in clinical laboratory--its national and international activities].
    Kawai T
    Rinsho Byori; 1993 Apr; 41(4):340-4. PubMed ID: 8350495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between in vitro susceptibility to antifungal drugs and the clinical evolution of patients with candidiasis and cryptococcosis].
    Viudes A; Cantón E; Pemán J; López-Ribot JL; Gobernado M
    Rev Esp Quimioter; 2002 Mar; 15(1):32-42. PubMed ID: 12582435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparisons of the in vitro susceptibility testing results for garenoxacin using six different national methods: report from the garenoxacin international bridging study.
    Jones RN; Gordon KA; Biedenbach DJ
    J Antimicrob Chemother; 2004 Feb; 53(2):258-65. PubMed ID: 14729758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic characteristics of coagulase-negative staphylococci: typing and antibiotic susceptibility.
    Jarløv JO
    APMIS Suppl; 1999; 91():1-42. PubMed ID: 10230367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Activity of ISO/TC212, clinical laboratory testing and in vitro diagnostic test systems].
    Kawai T
    Rinsho Byori; 1998 Oct; 46(10):961-7. PubMed ID: 9816905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility testing for mycobacteria.
    Woods GL
    Clin Infect Dis; 2000 Nov; 31(5):1209-15. PubMed ID: 11073754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibiotic resistance patterns of group B streptococcal clinical isolates.
    Simoes JA; Aroutcheva AA; Heimler I; Faro S
    Infect Dis Obstet Gynecol; 2004; 12(1):1-8. PubMed ID: 15460188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Situation analysis of occupational and environmental health laboratory accreditation in Thailand.
    Sithisarankul P; Santiyanont R; Wongpinairat C; Silva P; Rojanajirapa P; Wangwongwatana S; Srinetr V; Sriratanaban J; Chuntutanon S
    Southeast Asian J Trop Med Public Health; 2002 Jun; 33(2):400-9. PubMed ID: 12236443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antifungal susceptibility testing of yeasts: uses and limitations.
    Reyes G; Ghannoum MA
    Drug Resist Updat; 2000 Feb; 3(1):14-19. PubMed ID: 11498361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility of Streptococcus pneumoniae in New Zealand.
    Brett W; Masters PJ; Lang SD; Ikram RB; Hatch SH; Gordon MS
    N Z Med J; 1999 Mar; 112(1083):74-8. PubMed ID: 10210308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of Sensititre YeastOne vs. the NCCLS M27A protocol and E-test for antifungal susceptibility testing of yeasts.
    Lombardi G; Farina C; Andreoni S; Fazii P; Faggi E; Pini G; Manso E; Nanetti A; Mazzoni A
    Mycoses; 2004 Oct; 47(9-10):397-401. PubMed ID: 15504123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on clinical antifungal susceptibility testing for Candida species.
    Lewis RE; Klepser ME; Pfaller MA
    Pharmacotherapy; 1998; 18(3):509-15. PubMed ID: 9620102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mycoses].
    Yamazumi T; Furuta I
    Rinsho Byori; 2002 Sep; 50(9):853-9. PubMed ID: 12386962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should we reevaluate antibiotic breakpoints?
    Ferraro MJ
    Clin Infect Dis; 2001 Sep; 33 Suppl 3():S227-9. PubMed ID: 11524723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multilaboratory comparison of anaerobe susceptibility results using 3 different agar media.
    Roe DE; Finegold SM; Citron DM; Goldstein EJ; Wexler HM; Rosenblatt JE; Cox ME; Jenkins SG; Hecht DW
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S40-6. PubMed ID: 12173107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of susceptibility testing practices for Streptococcus pneumoniae--United States, February 2000.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2002 May; 51(18):392-4. PubMed ID: 12018795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of antimicrobial susceptibility testing.
    Barry AL
    Clin Lab Med; 1989 Jun; 9(2):203-19. PubMed ID: 2659241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antibiotic resistance and plasmid profiles of Escherichia coli in healthy human bodies].
    Fang M; Liu HC; Liu Q
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Nov; 38(6):1002-4. PubMed ID: 18095607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.